Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement
Angiology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via ISI Web of Science (2)
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Paraskevas, K. I.
Right arrow Articles by Mikhailidis, D. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Paraskevas, K. I.
Right arrow Articles by Mikhailidis, D. P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Thromboangiitis Obliterans (Buerger’s Disease): Searching for a Therapeutic Strategy

Kosmas I. Paraskevas, MD, FASA

Department of Vascular Surgery, Athens, Greece, Department of Clinical Biochemistry, Royal Free and University College Medical School, London, United Kingdom

Christos D. Liapis, MD, FACS, FRCS

Department of Vascular Surgery, Athens, Greece

Despina D. Briana, MD

Athens University Medical School, Athens, Greece

Dimitri P. Mikhailidis, MD, FASA, FFPM, FRCPath, FRCP

Department of Clinical Biochemistry, Royal Free and University College Medical School, London, United Kingdom, mikhailidis{at}aol.com

Treatment of thromboangiitis obliterans (Buerger’s disease) includes both surgical and nonsurgical approaches, or a combination of both. A definite therapeutic approach has not yet been set. This article reviews the proposed therapeutic strategies and considers the advantages and disadvantages of each treatment. Cessation of smoking seems to be the only globally accepted therapeutic measure to prevent disease progression. A number of promising novel therapeutic strategies may prove useful for the treatment of this physically and socially mutilating disease.

Angiology, Vol. 58, No. 1, 75-84 (2007)
DOI: 10.1177/0003319706291169
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




Advertisement